Genesis HealthCare (NYSE:GEN) EVP Joanne Susan Reifsnyder sold 7,488 shares of the company’s stock in a transaction dated Tuesday, June 5th. The stock was sold at an average price of $2.19, for a total value of $16,398.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of Genesis HealthCare stock traded down $0.01 during trading on Thursday, hitting $2.37. 17,594 shares of the stock traded hands, compared to its average volume of 898,272. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of -2.80. The firm has a market capitalization of $397.02 million, a PE ratio of -1.11 and a beta of 1.00. Genesis HealthCare has a 52 week low of $0.60 and a 52 week high of $2.50.
Genesis HealthCare (NYSE:GEN) last announced its quarterly earnings data on Thursday, May 10th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.36) by ($0.34). The firm had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the previous year, the business earned ($0.55) EPS. analysts predict that Genesis HealthCare will post -1.23 earnings per share for the current fiscal year.
Several equities analysts have recently commented on the company. ValuEngine lowered Genesis HealthCare from a “buy” rating to a “hold” rating in a research report on Monday, April 2nd. Stifel Nicolaus set a $2.00 price objective on Genesis HealthCare and gave the company a “hold” rating in a research report on Tuesday, April 24th. Finally, Stephens reiterated a “hold” rating and set a $2.00 price objective on shares of Genesis HealthCare in a research report on Monday, March 19th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $2.00.
Institutional investors have recently made changes to their positions in the company. Schwab Charles Investment Management Inc. bought a new position in shares of Genesis HealthCare during the 1st quarter valued at about $153,000. BSW Wealth Partners lifted its holdings in Genesis HealthCare by 74.2% in the 1st quarter. BSW Wealth Partners now owns 115,000 shares of the company’s stock worth $174,000 after buying an additional 49,000 shares during the period. Millennium Management LLC purchased a new stake in Genesis HealthCare in the 4th quarter worth approximately $184,000. Virtu Financial LLC purchased a new stake in Genesis HealthCare in the 4th quarter worth approximately $203,000. Finally, California Public Employees Retirement System lifted its holdings in Genesis HealthCare by 23.3% in the 1st quarter. California Public Employees Retirement System now owns 309,910 shares of the company’s stock worth $468,000 after buying an additional 58,610 shares during the period. Hedge funds and other institutional investors own 18.70% of the company’s stock.
Genesis HealthCare Company Profile
Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.
Receive News & Ratings for Genesis HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.